Sanofi, Principia agree to develop multiple sclerosis drug candidate
Sanofi will develop Principia Biopharma Inc.’s experimental oral treatment that shows promise in multiple sclerosis (MS) and, potentially, other central nervous system (CNS) diseases.…
Read More...
Read More...
